<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[the pharma industry Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/the+pharma+industry.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to the pharma industry]]></description>
	<s:counts start="0" returned="20" found="375" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Pfizer funds Canadian CME, prompting outcry]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/pfizer-funds-canadian-cme-prompting/22636/]]></link>
		<description><![CDATA[As some big-name hospitals and drugmakers back away from industry-funded medical education, the Canadian Medical Association has anted up. The CMA has teamed up with Pfizer on a nationwide educational campaign, backed by $780,000 in Pfizer funding. Predictably, the move has ignited criticism from ethicists and others. "[T]he pharmaceutical industry...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Thu, 03 Dec 2009 10:07:58 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Need to know: Toyota bonus cuts ... Future profits down ... DHL relocation ...]]></title>
		<link><![CDATA[http://industry.bnet.com/financial-services/news-analysis/toyota-bonus-cuts-profits-dhl/21987/]]></link>
		<description><![CDATA[View video and Need to Know interactive heatmap Economics Retail sales: A survey by the CBI showed that retail sales had risen at their fastest pace in two years during November and also showed that retailers expect a further rise next month. The gauge of sales rose to 13 in...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Thu, 26 Nov 2009 15:10:04 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/loss.html"><![CDATA[loss]]></category>
		<category domain="http://resources.bnet.com/topic/european+commission.html"><![CDATA[European Commission]]></category>
		<category domain="http://resources.bnet.com/topic/european+central+bank.html"><![CDATA[European Central Bank]]></category>
	</item>
	<item>
		<title><![CDATA[Abu Dhabi building $150m biologics plant]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/abu-dhabi-building-150m-biologics/21489/]]></link>
		<description><![CDATA[The United Arab Emirates UAE, which Abu Dhabi is part of, has made sizeable investments and offered incentives to boost its pharma industry, in part to diversify its industry beyond oil. Emirates Biotech Pharmaceutical Factory, a new company, will setup the facility to produce crystal insulin for diabetes, anti-cancers, vaccines,...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Mon, 23 Nov 2009 07:17:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/u.a.e..html"><![CDATA[U.A.E.]]></category>
		<category domain="http://resources.bnet.com/topic/abu+dhabi.html"><![CDATA[Abu Dhabi]]></category>
	</item>
	<item>
		<title><![CDATA[Julie Brill Nominated to FTC: A Message to Drug Manufacturers?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/julie-brill-nominated-ftc-message/21149/]]></link>
		<description><![CDATA[The Obama administration may have sent a subtle message to drug manufacturers Monday, when it nominated Julie Brill to be one of two new commissioners at the Federal Trade Commission. The message? Make sure your marketing practices don't collide with consumers' best interests.Brill has overseen consumer protection for states since...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Thu, 19 Nov 2009 12:06:52 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/ftc.html"><![CDATA[FTC]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
	</item>
	<item>
		<title><![CDATA[Hard to Get Excited about BI's Flibanserin]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/hard-excited-bis-flibanserin/20903/]]></link>
		<description><![CDATA[You might have missed the 12th Congress of the European Society for Sexual Medicine in Lyon, France, this week. If you did, US Phase III results for Boehringer Ingelheim's flibanserin might have passed you by, too. The drug--a serotonin 5-HT1A receptor agonist, 5-HT2A antagonist and partial dopamine agonist--is in development...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Wed, 18 Nov 2009 08:08:29 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/women.html"><![CDATA[Women]]></category>
	</item>
	<item>
		<title><![CDATA[WuXi Pharma Feels the Worst of the Downturn Is Over]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F173728-wuxi-pharma-feels-the-worst-of-the-downturn-is-over%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  WuXi PharmaTech (NYSE: WX), a bellwether for China&#8217;s CRO industry, reported a modest increase in Q3 revenues, but clearly feels the worst of the economic downturn is in the past. Revenues move up 10% to $70 million, and net income (non-GAAP) was 33% higher at $17.6...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 17 Nov 2009 01:11:15 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/wrangler+west+energy+corp..html"><![CDATA[Wrangler West Energy Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WX</category>
		<category domain="tickers">WX</category>
	</item>
	<item>
		<title><![CDATA[Drugmakers vow battle against House bill]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/drugmakers-vow-battle-house-bill/20502/]]></link>
		<description><![CDATA[With the U.S. House version of healthcare reform still moving forward, drugmakers are digging in. They're pledging to fight the House proposals it considers unfriendly to the industry, working closely with lobbyists and pushing back against sales projections that contradict industry talking points. AstraZeneca CEO David Brennan photo--who's also the...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Mon, 16 Nov 2009 08:47:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/industry.html"><![CDATA[Industry]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">DNA,RX</category>
	</item>
	<item>
		<title><![CDATA[Big Pharma execs top highest-paid Swiss list]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/pharma-execs-paid-swiss-list/20285/]]></link>
		<description><![CDATA[Who tops the list of highest-paid Swiss executives? None other than pharma's own Daniel Vasella photo, CEO of Novartis. Vasella's 2008 compensation grew by more than 20 percent from 2007, to 20.5 million francs. That's $20.24 million at today's exchange rates, $18.5 million as of Jan. 5, 2009. Vasella's crosstown...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Fri, 13 Nov 2009 05:55:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/executive.html"><![CDATA[executive]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
	</item>
	<item>
		<title><![CDATA[U.S. FDA tackles gray area of social media]]></title>
		<link><![CDATA[http://industry.bnet.com/technology/news-analysis/fda-tackles-gray-social-media/20158/]]></link>
		<description><![CDATA[By Deepa Seetharaman WASHINGTON (<a href="http://resources.bnet.com/index.php?source=Reuters">Reuters</a>)- Drug makers, Internet companies and nonprofits packed a hearing into what is a gray area for U.S. health regulators: how far Twitter, Wikipedia, blogs and other social media can go in promoting drugs. The two-day public hearing, convened Thursday by the Food and Drug Administration,...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Thu, 12 Nov 2009 11:21:53 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
	</item>
	<item>
		<title><![CDATA[Mashable’s Weekly Conference and Event Guide]]></title>
		<link><![CDATA[http://industry.bnet.com/technology/news-analysis/conference-event-guide/19574/]]></link>
		<description><![CDATA[ It's a brand new week, which means it's time for Mashable's guide to upcoming social media and web events, parties, and conferences. For more upcoming event listings, check out Mashable's  Events section .   Is your event not on this list? Contact us at least one month...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Mon, 09 Nov 2009 11:45:52 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/social+media.html"><![CDATA[Social Media]]></category>
		<category domain="http://resources.bnet.com/topic/event.html"><![CDATA[Event]]></category>
	</item>
	<item>
		<title><![CDATA[DotW: Sesame Street]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/dotw-sesame-street/19334/]]></link>
		<description><![CDATA[In case you failed to run a Google search this week, you may not have realized that on Tuesday Nov. 10, Sesame Street turns 40. You gotta admit, the show doesn't look a day over five--and that's without Botox.If you've forgotten how to get to Sesame Street, we have a...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Fri, 06 Nov 2009 08:36:19 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/development.html"><![CDATA[Development]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
	</item>
	<item>
		<title><![CDATA[Ask Your Doctor If This Ad Is Right for You]]></title>
		<link><![CDATA[http://industry.bnet.com/technology/news-analysis/doctor-ad/19213/]]></link>
		<description><![CDATA[By Arlene Weintraub Does it seem like you hear the phrase "ask your doctor" every time you turn on the TV? There's a reason. Drug companies spend about $5 billion a year in the U.S. on ads imploring people to talk to their physicians if they think a pill they've...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Thu, 05 Nov 2009 13:52:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[Advertisement]]></category>
	</item>
	<item>
		<title><![CDATA[ViiV chief vows joint venture will help battle HIV]]></title>
		<link><![CDATA[http://industry.bnet.com/healthcare/news-analysis/viiv-vows-joint-venture-battle/18873/]]></link>
		<description><![CDATA[The new head of the pioneering HIV joint venture between GlaxoSmithKline and Pfizer predicts his company can operate for at least five years without fresh funding from its shareholders. Dominique Limet, chief executive of ViiV Healthcare, which was formally launched yesterday, says it will generate £1.6bn a year in sales...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Wed, 04 Nov 2009 03:17:48 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/hiv+virus.html"><![CDATA[HIV Virus]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/intel+viiv.html"><![CDATA[Intel Viiv]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Johnson & Johnson to Overhaul Pharma, Cut 7,000 Jobs]]></title>
		<link><![CDATA[http://industry.bnet.com/technology/news-analysis/johnson-johnson-overhaul-pharma-cut/18853/]]></link>
		<description><![CDATA[By Arlene Weintraub The recession has slammed Johnson & Johnson JNJ, the world's largest health-care company. So, CEO William Weldon on Nov. 3 announced an overhaul that will result in layoffs of 6% to 7% of J&J's 117,000 employees, or more than 7,000 people. "We've gone through the headwinds that...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Tue, 03 Nov 2009 22:45:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="tickers">JNJ</category>
	</item>
	<item>
		<title><![CDATA[Mashable’s Weekly Conference Guide to Everything Social Media]]></title>
		<link><![CDATA[http://industry.bnet.com/technology/news-analysis/conference-guide-social-media/18539/]]></link>
		<description><![CDATA[ It's a brand new week, which means it's time for Mashable's guide to upcoming social media and web events, parties, and conferences. For more upcoming event listings, check out Mashable's  Events section .   Is your event not on this list? Contact us at least one month...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Mon, 02 Nov 2009 09:58:26 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/social+media.html"><![CDATA[Social Media]]></category>
		<category domain="http://resources.bnet.com/topic/event.html"><![CDATA[Event]]></category>
	</item>
	<item>
		<title><![CDATA[Covance Inc. Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-355411.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. We'll take our first question today from Mr. Greg Bolan with Wells Fargo. Greg Bolan - Wells Fargo Just thinking about Early Development activity these days and I realize this is an overly simplistic analogy, but it would appear to me that pharma has been...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 22 Oct 2009 11:19:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/wells+fargo+%2526+co..html"><![CDATA[Wells Fargo & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/covance+inc..html"><![CDATA[Covance Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/joe+herring+lumpy.html"><![CDATA[Joe Herring Lumpy]]></category>
		<category domain="http://resources.bnet.com/topic/managed+hosting.html"><![CDATA[Managed Hosting]]></category>
		<category domain="http://resources.bnet.com/topic/outsourcing.html"><![CDATA[Outsourcing]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/it+operations.html"><![CDATA[It Operations]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/outsourcing+%2526+subcontracting.html"><![CDATA[Outsourcing & Subcontracting]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WFC</category>
		<category domain="tickers">CVD,WFC</category>
	</item>
	<item>
		<title><![CDATA[NAMI pledges to back away from pharma money]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/nami-pledges-pharma-money/17051/]]></link>
		<description><![CDATA[Is the National Alliance on Mental Illness too close to Big Pharma? Could be, if money tells the story. After years of refusing to detail its funding sources, the advocacy group has had its piggybank busted wide open by Congressional investigators. And those investigators say NAMI gets the majority of...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Thu, 22 Oct 2009 08:55:27 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/industry.html"><![CDATA[Industry]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
	</item>
	<item>
		<title><![CDATA[Merck pays $3m in speaker fees to US doctors]]></title>
		<link><![CDATA[http://industry.bnet.com/healthcare/news-analysis/merck-pays-3m-speaker-fees/16714/]]></link>
		<description><![CDATA[Merck paid more than $3m in speaker fees to US doctors during the second quarter of this year, according to figures from the company that represent a step towards greater transparency in the New Jersey-based pharmaceutical group's commercial links with prescribers. The company has provided less information, however, than Eli...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Tue, 20 Oct 2009 20:22:43 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">LLY,MRK</category>
	</item>
	<item>
		<title><![CDATA[Merck reveals doctors' speaker fees after calls for transparency]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F69646776-bdd9-11de-9f6a-00144feab49a.html&siteid=23&tag=financialtimes]]></link>
		<description><![CDATA[ Merck paid more than $3m in speaker fees to US doctors during the second quarter of this year, according to figures from the company that represent a step towards greater transparency in the commercial links of the New Jersey-based pharmaceutical group with prescribers.The company has provided less information, however,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 20 Oct 2009 19:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/payment.html"><![CDATA[Payment]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/company+news.html"><![CDATA[Company News]]></category>
		<category domain="http://resources.bnet.com/topic/general+news.html"><![CDATA[General News]]></category>
		<category domain="http://resources.bnet.com/topic/health+%2526+healthcare.html"><![CDATA[Health & Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/financial+times.html"><![CDATA[Financial Times]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">LLY,MRK</category>
	</item>
	<item>
		<title><![CDATA[Alabama court gives upset victory to pharma]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/alabama-court-upset-victory-pharma/16390/]]></link>
		<description><![CDATA[In a turnabout victory for drugmakers, the Alabama Supreme Court has overturned $274 million in jury verdicts. The juries had awarded money to the state, based on accusations that AstraZeneca, Novartis and GlaxoSmithKline had overcharged Medicaid for their drugs. But Alabama's top court essentially said that if the state were...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Mon, 19 Oct 2009 12:22:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/alabama.html"><![CDATA[Alabama]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+supreme+court.html"><![CDATA[U.S. Supreme Court]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
</channel>
</rss>
